Eradication of Helicobacter pylori: which patients, which drugs?

Helicobacter pylori, first detected in gastritis patients a decade ago, has now been shown to be the major cause of active chronic gastritis, and the evidence that it plays a major role in the pathophysiology of duodenal ulcers and possibly gastric ulcers is compelling. The infection is generally di...

Descripción completa

Detalles Bibliográficos
Publicado en:Physician Assistant Vol. 17; no. 4; pp. 65 - 72
Autores principales: DeCross AJ, Marshall BJ
Formato: CEU exam questions pictorial tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins 1993 Apr
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Helicobacter pylori, first detected in gastritis patients a decade ago, has now been shown to be the major cause of active chronic gastritis, and the evidence that it plays a major role in the pathophysiology of duodenal ulcers and possibly gastric ulcers is compelling. The infection is generally diagnosed at the initial endoscopy by means of a rapid urease test, but it may be detected by serologic testing in patients not undergoing endoscopy. Treatment of the infection should be reserved for patients with duodenal ulcer disease that presents a significant management problem. The recommended therapy, commonly referred to as triple therapy, consists of bismuth subsalicylate, tetracycline, and metronidazole and has an 80% to 90% eradication success rate.